110 related articles for article (PubMed ID: 3877979)
21. Interleukin-1 restores the impaired cytotoxic T lymphocyte generation in beige mutant mouse.
Okuno K; Takatsu K; Takahama Y; Kitamura Y; Hamaoka T
Gan; 1984 Sep; 75(9):824-32. PubMed ID: 6238864
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 2 is not sufficient for the continuous growth of cloned NK-like cytotoxic cell lines.
Olabuenaga SE; Brooks CG; Gillis S; Henney CS
J Immunol; 1983 Nov; 131(5):2386-91. PubMed ID: 6605387
[TBL] [Abstract][Full Text] [Related]
23. Antigen-independent activation of cytotoxic T cells by lymphokines.
Williams LD; McMaster WR; Teh HS
Immunology; 1988 May; 64(1):121-8. PubMed ID: 3133307
[TBL] [Abstract][Full Text] [Related]
24. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
Nahill SR; Welsh RM
J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
[TBL] [Abstract][Full Text] [Related]
25. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
26. Generation of cytotoxic cells from murine bone marrow by human recombinant IL 2.
Koo GC; Manyak CL
J Immunol; 1986 Sep; 137(6):1751-6. PubMed ID: 2427580
[TBL] [Abstract][Full Text] [Related]
27. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
Claesson MH; Miller RG
J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
[TBL] [Abstract][Full Text] [Related]
28. Antigen-presenting T cells. I. Class I alloantigen (bm1)-bearing T lymphoblasts efficiently stimulate a primary clonal response of Lyt-2+ cytotoxic lymphocyte precursors of B6 origin.
Reimann J; Bellan A; Kabelitz D
J Immunol; 1987 Feb; 138(4):1042-50. PubMed ID: 3492539
[TBL] [Abstract][Full Text] [Related]
29. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
Ting CC; Hargrove ME
J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
[TBL] [Abstract][Full Text] [Related]
30. IL-10: a novel cytotoxic T cell differentiation factor.
Chen WF; Zlotnik A
J Immunol; 1991 Jul; 147(2):528-34. PubMed ID: 1906502
[TBL] [Abstract][Full Text] [Related]
31. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
32. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells.
Hardt C; Diamantstein T; Wagner H
Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.
Nakajima F; Khanna A; Xu G; Lagman M; Haschemeyer R; Mouradian J; Wang JC; Stenzel KH; Rubin AL; Suthanthiran M
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7889-93. PubMed ID: 8058730
[TBL] [Abstract][Full Text] [Related]
34. Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2.
Merluzzi VJ; Savage DM; Mertelsmann R; Welte K
Cell Immunol; 1984 Mar; 84(1):74-84. PubMed ID: 6199125
[TBL] [Abstract][Full Text] [Related]
35. Generation of natural killer-like cytotoxicity from human thymocytes with interleukin-2.
Gray JD; Torten M; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(3):124-33. PubMed ID: 6209571
[TBL] [Abstract][Full Text] [Related]
36. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
37. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
[TBL] [Abstract][Full Text] [Related]
38. Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. I. Requirement of both killer-helper factor(s) and interleukin 2 for CTL generation from a subpopulation of thymocytes.
Takatsu K; Kikuchi Y; Kanatani T; Okuno K; Hamaoka T; Tominaga A; Sano Y
J Immunol; 1986 Feb; 136(4):1161-70. PubMed ID: 3080519
[TBL] [Abstract][Full Text] [Related]
39. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
Yang SS; Malek TR; Hargrove ME; Ting CC
J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
[TBL] [Abstract][Full Text] [Related]
40. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
